On Friday, Shares of Tenet Healthcare Corp (NYSE:THC), lost -1.21% to $47.24.
Tenet Healthcare Corporation, senior administration will take part in the following investor conferences in September 2015:
- Baird 2015 Healthcare Conference in New York on Wednesday, September 9, 2015 at about 8:30 a.m. EDT.
- 2015 Wells Fargo Healthcare Conference in Boston on Thursday, September 10, 2015 at about 8:00 a.m. EDT.
- Morgan Stanley Global Healthcare Conference in New York on Wednesday, September 16, 2015 at about 9:20 a.m. EDT.
Tenet Healthcare Corporation, a healthcare services company, primarily operates acute care hospitals and related healthcare facilities in the United States. It operates through two segments, Hospital Operations and Other, and Conifer.
At the end of Friday’s trade, Shares of DaVita HealthCare Partners Inc (NYSE:DVA), lost -1.18% to $74.55.
DaVita HealthCare Partners declared that it has named Lauren Edgington as chief financial officer (CFO) for HealthCare Partners’ Florida market.
Edgington joins DaVita HealthCare Partners from Aetna, where she was regional chief financial officer. In that role, she was responsible for financial operations for Medicaid and dual demonstration lines of business within the Midwest and Southeast regions.
“During this period of growth, HealthCare Partners will benefit immensely from Lauren’s extensive experience in finance and managed care,” said Lorie Glisson, HealthCare Partners’ Florida market president and CEO. “Her strong record of meeting key financial and operational results, in combination with her commitment to our cultural values, makes her an invaluable addition to our team.”
DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure or end stage renal disease (ESRD). The company operates in two divisions, Kidney Care and HealthCare Partners.
Finally, Cerus Corporation (NASDAQ:CERS), ended its last trade with 6.29% gain, and closed at $5.24.
Cerus Corporation declared that Kevin Green, Cerus’ vice president and chief financial officer, is planned to present a corporate update at the Baird 2015 Healthcare Conference at 3:45 PM ET on Wednesday, September 9, 2015.
Cerus Corporation operates as a biomedical products company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System is based on its proprietary technology for controlling biological replication and designed to target and inactivate blood-borne pathogens, counting viruses, bacteria, and parasites, in addition to potentially harmful white blood cells, while preserving the therapeutic properties of platelet, plasma, and red blood cell transfusion products.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
